CME (CME) | Financial Analysis & Statements
CME Group Inc. Large-cap Financial Services
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
1.6B
Gross Profit
1.4B
85.38%
Operating Income
1.0B
61.84%
Net Income
1.2B
71.75%
EPS (Diluted)
$3.24
Balance Sheet Metrics
Total Assets
198.4B
Total Liabilities
169.7B
Shareholders Equity
28.7B
Debt to Equity
5.91
Cash Flow Metrics
Operating Cash Flow
1.4B
Free Cash Flow
1.1B
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
CME Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 6.5B | 6.1B | 5.6B | 5.0B | 4.7B |
| Cost of Goods Sold | 907.0M | 850.3M | 828.6M | 753.1M | 837.0M |
| Gross Profit | 5.6B | 5.3B | 4.8B | 4.3B | 3.9B |
| Gross Margin % | 86.1% | 86.1% | 85.1% | 85.0% | 82.2% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 150.5M | 132.7M | 144.4M | 137.4M | 151.7M |
| Other Operating Expenses | 902.7M | 878.8M | 817.6M | 750.4M | 670.4M |
| Total Operating Expenses | 1.1B | 1.0B | 962.0M | 887.8M | 822.1M |
| Operating Income | 4.2B | 3.9B | 3.4B | 3.0B | 2.6B |
| Operating Margin % | 64.9% | 64.1% | 61.6% | 60.1% | 56.4% |
| Non-Operating Items | |||||
| Interest Income | - | - | - | - | - |
| Interest Expense | 173.4M | 160.9M | 159.4M | 162.7M | 166.9M |
| Other Non-Operating Income | 1.3B | 770.8M | 877.3M | 637.1M | 895.3M |
| Pre-tax Income | 5.3B | 4.5B | 4.2B | 3.5B | 3.4B |
| Income Tax | 1.3B | 1.0B | 927.4M | 799.3M | 736.7M |
| Effective Tax Rate % | 23.6% | 22.4% | 22.3% | 22.9% | 21.8% |
| Net Income | 4.1B | 3.5B | 3.2B | 2.7B | 2.6B |
| Net Margin % | 62.5% | 57.5% | 57.8% | 53.6% | 56.2% |
| Key Metrics | |||||
| EBITDA | 98.3M | 960.0M | -609.7M | 1.8B | 3.6B |
| EPS (Basic) | $11.18 | $9.69 | $8.87 | $7.41 | $7.30 |
| EPS (Diluted) | $11.16 | $9.67 | $8.86 | $7.40 | $7.29 |
| Basic Shares Outstanding | 359648000 | 359389000 | 359023000 | 358713000 | 358340000 |
| Diluted Shares Outstanding | 359648000 | 359389000 | 359023000 | 358713000 | 358340000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
CME Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 4.4B | 2.9B | 2.9B | 2.7B | 2.8B |
| Short-term Investments | 125.0M | 113.2M | 111.7M | 96.0M | 115.0M |
| Accounts Receivable | 639.2M | 573.1M | 535.6M | 483.2M | 434.5M |
| Inventory | - | - | - | - | - |
| Other Current Assets | 515.6M | 553.1M | 1.1B | 524.9M | 423.0M |
| Total Current Assets | 165.4B | 103.0B | 94.9B | 139.1B | 161.8B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 40.8B | 41.0B | 41.2B | 41.4B | 41.8B |
| Intangible Assets | 19.8B | 20.0B | 20.2B | 20.4B | 20.7B |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 2.4B | 3.5B | 3.7B | 3.7B | 3.3B |
| Total Non-Current Assets | 33.1B | 34.4B | 34.8B | 35.1B | 35.0B |
| Total Assets | 198.4B | 137.4B | 129.7B | 174.2B | 196.8B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 71.8M | 79.9M | 90.6M | 121.4M | 48.8M |
| Short-term Debt | - | 749.8M | - | 16.0M | 749.4M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 160.2B | 101.5B | 93.3B | 137.6B | 159.6B |
| Total Current Liabilities | 160.3B | 102.3B | 93.4B | 137.7B | 160.4B |
| Non-Current Liabilities | |||||
| Long-term Debt | 3.4B | 2.7B | 3.4B | 3.4B | 2.7B |
| Deferred Tax Liabilities | 5.2B | 5.2B | 5.3B | 5.4B | 5.4B |
| Other Non-Current Liabilities | 734.8M | 721.2M | 798.2M | 826.0M | 896.5M |
| Total Non-Current Liabilities | 9.4B | 8.6B | 9.6B | 9.6B | 9.0B |
| Total Liabilities | 169.7B | 111.0B | 103.0B | 147.3B | 169.4B |
| Equity | |||||
| Common Stock | 3.6M | 3.6M | 3.6M | 3.6M | 3.6M |
| Retained Earnings | 6.4B | 4.2B | 4.5B | 4.7B | 5.2B |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 28.7B | 26.5B | 26.7B | 26.9B | 27.4B |
| Key Metrics | |||||
| Total Debt | 3.4B | 3.4B | 3.4B | 3.4B | 3.4B |
| Working Capital | 5.1B | 719.6M | 1.5B | 1.4B | 1.4B |
Balance Sheet Composition
CME Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 4.1B | 3.5B | 3.2B | 2.7B | 2.6B |
| Depreciation & Amortization | 330.9M | 336.8M | 352.6M | 362.6M | 385.4M |
| Stock-Based Compensation | 94.8M | 89.5M | 82.9M | 84.3M | 75.2M |
| Working Capital Changes | 8.6M | -71.2M | -18.1M | 52.6M | -41.3M |
| Operating Cash Flow | 4.5B | 3.8B | 3.6B | 3.2B | 3.1B |
| Investing Activities | |||||
| Capital Expenditures | -83.5M | -94.0M | -76.4M | -89.7M | -87.9M |
| Acquisitions | 1.6B | 9.9M | 95.5M | -402.0M | 144.7M |
| Investment Purchases | -6.0M | -4.5M | -4.1M | -4.4M | -7.8M |
| Investment Sales | 7.9M | 6.0M | 5.9M | 6.3M | 9.4M |
| Investing Cash Flow | 1.5B | -82.6M | 20.9M | -489.8M | 58.4M |
| Financing Activities | |||||
| Share Repurchases | -266.1M | - | - | - | - |
| Dividends Paid | -3.9B | -3.6B | -3.2B | -2.6B | -2.2B |
| Debt Issuance | 740.6M | 0 | 0 | 741.0M | 0 |
| Debt Repayment | -750.0M | 0 | -16.4M | -756.2M | 0 |
| Financing Cash Flow | 56.5B | 5.1B | -48.3B | -25.4B | 69.9B |
| Free Cash Flow | 4.2B | 3.6B | 3.4B | 3.0B | 2.3B |
| Net Change in Cash | 62.5B | 8.8B | -44.7B | -22.7B | 73.0B |
Cash Flow Trend
CME Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
24.34
Forward P/E
22.14
Price to Book
3.57
Price to Sales
15.36
PEG Ratio
1.03
Profitability Ratios
Profit Margin
63.31%
Operating Margin
69.66%
Return on Equity
15.92%
Return on Assets
1.55%
Financial Health
Current Ratio
1.02
Debt to Equity
12.86
Beta
0.30
Per Share Data
EPS (TTM)
$11.73
Book Value per Share
$80.03
Revenue per Share
$18.76
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| CME | 103.4B | 24.34 | 3.57 | 15.92% | 63.31% | 12.86 |
| S&P Global | 130.5B | 29.75 | 4.19 | 13.09% | 29.15% | 37.91 |
| Intercontinental | 89.4B | 27.53 | 3.11 | 11.89% | 33.38% | 70.08 |
| Moody's | 79.7B | 32.74 | 26.93 | 71.36% | 31.69% | 232.68 |
| Coinbase Global | 52.8B | 45.19 | 3.64 | 10.06% | 18.31% | 53.12 |
| Nasdaq | 49.7B | 28.35 | 4.08 | 15.25% | 34.06% | 77.88 |
Financial data is updated regularly. All figures are in the company's reporting currency.






